Fat intake at midlife and risk of dementia and Alzheimer's disease: A population-based study

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 1, 2006, Pages 99-107

  Laitinen, M H ^b   Ngandu, T ^a   Rovio, S ^a   Helkala, E L ^b   Uusitalo, U ^d   Viitanen, M ^a   Nissinen, A ^d   Tuomilehto, J ^d   Soininen, H ^b,c   Kivipelto, M ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dietary fat intake

Indexed keywords

APOLIPOPROTEIN E4; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DEMENTIA; DIETARY INTAKE; FAT INTAKE; FEMALE; FOLLOW UP; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SAMPLE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLESTEROL; DATA COLLECTION; DEMENTIA; DIETARY FATS; DIETARY FATS, UNSATURATED; FEMALE; FINLAND; FOLLOW-UP STUDIES; FOOD HABITS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POPULATION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; SOCIOECONOMIC FACTORS;

EID: 33745191471     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093478     Document Type: Article

References (36)

1. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
2. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
3. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A: Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
4. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000;21:49-55.
5. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-1451.
6. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H: Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002;137:149-155.
7. de la Torre JC: Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152-1162.
8. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MMB: Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997;42:776-782.
9. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC, Breteler MM: Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology 2002;59:1915-1921.
10. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Schneider J, Wilson RS: Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003;60:194-200.
11. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940-946.
12. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S: Fish, meat, and risk of dementia: cohort study. BMJ 2002;325:932-933.
13. Luchsinger JA, Tang MX, Shea S, Mayeux R: Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002;59:1258-1263.
14. Puska P, Tuomilehto J, Salonen J, Neittaanmaki L, Maki J, Virtamo J, Nissinen A, Koskela K, Takalo T: Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). BMJ 1979;2:1173-1178.
15. Puska P, Salonen JT, Nissinen A, Tuomilehto J, Vartiainen E, Korhonen H, Tanskanen A, Ronnqvist P, Koskela K, Huttunen J: Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). BMJ (Clin Res Ed) 1983;287:1840-1844.
16. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A: Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol 1994;23:495-504.
17. WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-114.
18. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001;56:1683-1689.
19. Pietinen P, Vartiainen E, Korhonen HJ, Kartovaara L, Uusitalo U, Tuomilehto J, Puska P: Nutrition as a component in community control of cardiovascular disease (the North Karelia Project). Am J Clin Nutr 1989;49:1017-1024.
20. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T: Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
21. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
24. Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H: Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 1999;249(suppl 3):14-22.
25. Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM: Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 2000;48:201-210.
26. Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ: Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol 2004;56:745-748.
27. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O: Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 2002;81:1084-1091.
28. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N,Jr, Ashe KH, Frautschy SA, Cole GM: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004;43:633-645.
29. Blok WL, Katan MB, van der Meer JW: Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996;126:1515-1533.
30. James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71:343S-348S.
31. Butterfield DA, Drake J, Pocernich C, Castegna A: Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 2001;7:548-554.
32. Sohal RS, Weindruch R: Oxidative stress, caloric restriction, and aging. Science 1996;273:59-63.
33. Pietinen P, Uusitalo U, Vartiainen E, Tuomilehto J: Dietary survey of the FINMONICA project in 1982. Acta Med Scand Suppl 1988;728:169-177.
34. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
35. Anttila T, Helkala EL, Viitanen M, Kareholt I, Fratiglioni L, Winblad B, Soininen H, Tuomilehto J, Nissinen A, Kivipelto M: Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ 2004;329:539-542.
36. Bunce D, Kivipelto M, Wahlin A: Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older. Neuropsychology 2004;18:362-370.